[Systematic extended lymph node dissection in curative therapy of stomach cancer].
On 545 patients with gastric carcinoma treated surgically for cure during June, 1, 1982 and December, 31, 1989 the value of the systematic extended lymph node dissection (SELD) was studied prospectively. In SELD neither surgical mortality nor postoperative complications were observed with increasing frequency. In stage II survival was significantly improved in patients with SELD, in stages IA, IB and IIIA an analogous trend was seen. Patients in stage IIIB and IV showed with and without SELD identical survival.
Gall
F P
FP
Chirurgische Klinik mit Poliklinik, Friedrich-Alexander-Universität Erlangen.
Hermanek
P
P
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002277:Carcinoma / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D005260:Female; D005743:Gastrectomy / Q000379:methods; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods*; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011183:Postoperative Complications / Q000401:mortality; D013274:Stomach Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D015996:Survival Rate
Die systematische erweiterte Lymphknotendissektion in der kurativen Therapie des Magencarcinoms.